期刊文献+

乳腺癌保乳术后螺旋断层治疗技术的剂量学研究 被引量:15

Study the dosimetric for whole breast irradiation with fixed field IMRT and helical tomotherapy
原文传递
导出
摘要 目的研究乳腺癌保乳术后患者应用固定野调强放疗(FF-IMRT)和螺旋断层治疗(HT)计划的剂量学差异。方法选择10例左侧乳腺癌保乳术后IMRT患者,CT模拟定位、勾画靶区及危及器官,对同-CT图像设计FF—IMRT计划和HT计划。配对t检验两种计划靶区及危及器官剂量分布及照射时间差异。结果与FF—IMRT计划相比,HT计划的100%PTV覆盖度增加(P110.000),105%PTV覆盖度降低(P110.000),平均剂量(Dmean)降低(P=0.002),均匀指数(HI)、适形指数(CI)增加(P=0.001、0.023)。HT计划的患侧肺剂量体积V5、V10、V20、V30、V40、Dmean。分别降低28%、30%、35%、46%、61%、32%(P=0.000),双肺的分另0降低30%、28%、34%、46%、62%、26%(P=0.000),心脏的和最大剂量(Dmax)分别降低57%、59%、71%、82%、91%、45%和12%(P=0.000~0.002),健侧乳腺Dmean、Dmax分别增加0.9、3.0Gy(P=0.000、0.000),健侧肺的分别增加0.42、2.70Gy(P=0.000、0.000)。HT计划照射时间明显高于FF—IMRT计划(11.98min:5.96min,P=0.000)。结论左侧如乳腺癌HT计划的靶区均匀性和适形度均优于FF—IMRT计划,危及器官可获得等同于或优于FF—IMRT计划的剂量分布,可作为新照射方式用于乳腺癌保乳术后患者。 Objective To compare the dosimetry difference between helical tomotherapy and fixed field IMRT for breast cancer radiotherapy after breast-conserving surgery. Methods Ten patients received radiotherapy after breast-conserving surgery were selected. For each patient, two treatment plans (FF-IMRT plan and HT plan) were designed with Eclipse and TomoTberapy. Same institutional dose-volume constraints for breast cancer were used in both techniques. Targets and organs at risk were compared with paired t-test for two planning. Results In comparison with the FF-IMRT planning, PTV coverage of HT plan group increased, Dine became lower (P =0. 000,0. 002). the HI and CI were significantly higher for HT (P = 0. 001,0. 023 ). Compared with the FF-IMRT plans, V5 , Vi0, V20, V30, V40 and D of the ipsilateral lung were reduced by about 28% ,30% ,35% ,46% ,61% and 32% ( P = 0. 000) , those of full lung were reduced by about 30% ,28% ,34% ,46% ,62% and 26% (P=0.000) , those and Dmax of heart were reduced by about 57%,59%,71%,82%,91%,45% and 12% (P= 0.000=43.002). The D and Dmax of contralateral breast were higher by 0. 9 Gy and 3.0 Gy ( P = 0. 000, 0. 000 ) respectively, those of contralateral lung were higher by 0. 42 Gy and 2. 70 Gy ( P = 0. 000, 0. 000 ) respectively. It takes significantly long time for the HT plans designed than FF-IMRT plan ( 11.98 rain : 5.96 min, P = 0. 000 ). Conclusions The HT planning improve the HI and CI of PTV, organs at risk can get equivalent or superior dose distribution compared with the FF-IMRT technology, but it is feasible for clinical applications in breast- conserving surgery as a new method.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2013年第5期411-414,共4页 Chinese Journal of Radiation Oncology
关键词 乳腺肿瘤 固定野调强放射疗法 乳腺肿瘤 螺旋断层疗法 剂量学 Breast neoplasms/fixed field intensity-modulated radiotherapy Breast neoplasms/ helical tomotherapy Dosimetry
  • 相关文献

参考文献10

  • 1Lohr F, E1-Haddad M, Dobler B, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys,2009,74:73-80.
  • 2Hurkmans C, Cho B, Damen E, et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Onco1,2002,62 : 163-171.
  • 3Mackie T, Holmes T, Swerdloff S, et al. Tomotherapy : a new concept for the delivery of dynamic conformal radiotherapy. Med Phys, 1993,20 : 1709-1720.
  • 4Pigno JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol, 2008,26 : 2085- 2092.
  • 5Graham MV, Purdy JA, Emami B, et al. Preliminary result of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol phys,1995,33:993-1000.
  • 6Schubert LK, Gondi V, Sengbusch E, et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol, 2011,100 : 241- 246.
  • 7Gyenes G, Gagliardi G, Lax I,et al. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol, 1997,15:1348- 1353.
  • 8Unnithan J, Macklis RM. Contralateral breast cancer risk. Radiother Onco1,2001,60:239-246.
  • 9Meeks SL, Buatti JM, Bova FJ, et al. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys, 1998,40:483-495.
  • 10Goddu SM, Yaddanapudi S, Pechenaya OL, et al. Dosimetric consequences of uncorrected setup errors in helical tomotherapy treatments of breast-cancer patients. Radiother Oncol, 2009,93 : 64-70.

同被引文献99

引证文献15

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部